Pharma-on-Demand

Make or buy? That is the question that the pharma world has been asking more and more in the last couple of decades. Pernille Hemmingsen is moderator at Pharma ...

How to become globally competitive

Here Gunilla Osswald from BioArctic share her experience of scaling up and be competative on the global arena.

Drug development creates new challenges for regulators

Lucy Robertshaw: There is a bio revolution happening right now

Lucy Robertshaw is both proud and excited to be taking the baton of moderating this year’s Pharma Outsourcing event.

Marie Gårdmark: Do EMA and FDA talk to each other?

Of course they do! The collaboration started already in 2003, writes Marie Gårdmark in a column.

Combining two drug delivery strategies to improve bioavailability

Danish researchers hope to increase the bioavailability of low solubility drugs.

"Unclear proposal from the EU Commission on how to solve the MDR challenges"

Even before the EU regulation on medical devices (MDR) came into force, medical technology companies and doctors were concerned that it would endanger the avail...

Ny modell ger ytterligare stöd för munskydd: ”Ger ett utmärkt skydd”

Forskare vid bland annat Chalmers har tagit fram en modell för att mäta hur virus färdas genom luften – och hur effektivt munskydd är för att hindra smittspridn...

Swedish Healthtech Company 1928 Pushing Forward

The full service analytics platform is expanding the business.

It´s time to establish relations

Communication with the patient is the key to future healthcare, writes Hanna Brodda, editor in chief of Life Science Sweden.

Helena Strigård: The rise of the community

Sweden Bio´s CEO is looking back at the last decade of development in the industry. Something has shifted in the interdependence between small and larger companies.

Pharma Outsourcing igång på Stockholm Waterfront

Column: Why there cannot be a complete cure for cancer – but there is certainly another way!

"Is there a new way we need to be thinking about how to prevent cancer?" Lucy Robertshaw reflects upon which is the smartest way to beat cancer.

Column: "Are we already living in the new normal?"

2020 felt like the year that we were building the house around us whilst moving into it at the same time.

CDC varnar för stigmatisering vid postcovid

Den amerikanska smittskyddsmyndigheten, CDC, uppmanar läkare att ha ett empatiskt förhållningssätt vid behandling av patienter med postcovid.

The perfect formula for decision-making

No one has the luxury not to take a decision, writes Helena Strigård at Swedenbio.

Meet the governmental life science office

More clinical trials, promotion for digitisation and interoperability together with increased use of data generated by both healthcare and individuals. The duti...

The best wealth is Health

We are living in a world where wealth more and more is measured in being able to do the things you like and enjoy in life. As the wealth increases in terms of e...

Forskare undersökte syrapumpshämmare med datorsimuleringar – gör koppling till demens

Forskare från Karolinska institutet har i en preklinisk studie sett en mekanism som de anser pekar på att långvarig användning av syradämpande läkemedel kan bid...

Giulia Gaudenzi: ”Key lessons from global health research”

The world will still face major challenges in the post Covid-19 pandemic, writes Giulia Gaudenzi at the KTH Division of Nanobiotechnology at Scilifelab, in a column.

Brexit creeping closer – or?

In this column, lawyer Pernilla Norman, tries to sort out the different Brexit options.

They’re all doing it – buying drug research

It is not easy to navigate the complex infrastructure for drug development in Sweden, where various contract players exist alongside the pharmaceutical companies.

Första resultaten för nygammalt läkemedel mot covid-19

I en ny studie förbättrades tillståndet för 68 procent av patienter med allvarlig covid-19 när de fick läkemedlet remdesivir. Men studien har flera svagheter oc...

Pilots want to live too